Siemens Fonds Invest’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Siemens Fonds Invest's BIIB Position: Q2 2026 in Review
Siemens Fonds Invest held its Biogen (BIIB) position steady in Q2 2026 at 3,633 shares worth $785K. The position accounts for 0.04% of the portfolio, ranked #290.
Siemens Fonds Invest first reported a position in BIIB in Q3 2021 and has held it in 20 quarters since. The position peaked at $1.91M in Q2 2023. 1,038 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Siemens Fonds Invest held 3,633 shares of Biogen worth $785K as of Q2 2026.
- Siemens Fonds Invest left its Biogen share count unchanged in Q2 2026.
- Biogen made up 0.04% of Siemens Fonds Invest's portfolio in Q2 2026, its #290 holding.
- Siemens Fonds Invest first reported a position in Biogen in Q3 2021 and has held it in 20 quarters since.
- Siemens Fonds Invest's Biogen position peaked at $1.91M in Q2 2023.
- 1,038 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Siemens Fonds Invest's 13F filing for Q2 2026, filed 14 Aug 2026.